p53 expression and prognosis in gastric carcinoma
✍ Scribed by Hilary M. Martin; M. Isabel Filipe; Richard W. Morris; David P. Lane; Frederico Silvestre
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- French
- Weight
- 960 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Abnormalities of the p53 gene have been identified in many malignancies, with reports of aberration in over half of colorectal, lung, breast and hepatocellular carcinoma cases. The normal gene acts as a recessive oncogene, while mutations change the apparent function to that of a dominant oncogene.
In this investigation a 3‐layered immunoperoxidase technique was applied to routinely fixed and paraffin‐embedded tissue sections from 125 gastric carcinomas, using a polyclonal anti‐p53 antibody (CM‐1).
We found that 57% of these carcinomas expressed high levels of p53 protein (positive nuclear staining). Survival analysis revealed a strong association between p53 status of the tumour and patient survival time after diagnosis (p = 0.02, Mantel‐Cox Test); odds ratio of death, 2.09 (95% confidence interval 1.02 to 4.25). The 5‐year survival of patients with p53‐expressing tumours was 24%, compared with 56% for those non‐p53‐expressing tumours (the median survival times were 13 and 102 months, respectively).
📜 SIMILAR VOLUMES
With regard to prognosis, patients whose tumors had both First Department of Surgery, Nara Medical Unistrong positivity for cyclin E and positivity for p53 had significantly poorer prognosis. versity, Nara, Japan. In multivariate analysis, the combined variable of cyclin E and p53 was an independen
## Abstract Human Chk1 and Chk2 are DNA damage–activated protein kinases that function as downstream mediators of ataxia‐telangiectasia mutated (ATM), which is involved in G~2~/M cell cycle arrest. To clarify the relation between the expression of Chk1/Chk2 and __p53__ gene status in human gastric
Gastric dysplasia (high-grade, HGD, and low-grade, LGD) and normal mucosa were tested for anti-pf3, anti-Ki-67 and anti-PCNA monoclonal antibodies on paraffin sections, and for relative AgNOR area and number on semithin Epon-Araldite sections. The proliferative compartment in normal mucosa was restr